Clearpoint Neuro Net Worth

Clearpoint Neuro Net Worth Analysis

Know Clearpoint Neuro's Top Institutional Investors

Note, although Clearpoint Neuro's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Clearpoint Neuro's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 401.22 M.

Project Clearpoint Neuro's profitablity

The company has Profit Margin (PM) of (0.6) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.64) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.64.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Clearpoint Neuro's management efficiency

Clearpoint Neuro has return on total asset (ROA) of (0.2804) % which means that it has lost $0.2804 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6836) %, meaning that it created substantial loss on money invested by shareholders. Clearpoint Neuro's management efficiency ratios could be used to measure how well Clearpoint Neuro manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.51 in 2025. Return On Capital Employed is likely to drop to -0.72 in 2025. At this time, Clearpoint Neuro's Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 1.6 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 24.6 M in 2025.

Clearpoint Neuro Corporate Filings

Clearpoint Neuro time-series forecasting models is one of many Clearpoint Neuro's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Clearpoint Neuro's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Clearpoint Neuro Earnings per Share Projection vs Actual

Clearpoint Neuro Corporate Management

Additional Tools for Clearpoint Stock Analysis